Back to 
Assenagon Asset Management S.A.
Assenagon Asset Management S.A.
CORT
Showing 0 of 4 quarters
Position history for Assenagon Asset Management S.A.'s holdings in Corcept Therapeutics Incorporated.
No. Assenagon Asset Management exited its CORT (Corcept Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 349,667 shares worth $6.1M. Assenagon Asset Management first reported CORT in Q1 2020 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.